BioHorizons, Inc., a majority-owned subsidiary of Henry Schein, Inc. (NASDAQ:HSIC), is a leading dental implant and biologics company located in Birmingham, Alabama. The company has a broad product offering, including dental implants, surgical planning software and tissue regeneration solutions for the replacement of missing teeth. BioHorizons products are available in 85 markets around the world. For more information, visit biohorizons.com.
Looking for a particular BioHorizons employee's phone or email?
The BioHorizons annual revenue was $175.5 million in 2026.
Steve Boggan is the CEO of BioHorizons.
383 people are employed at BioHorizons.
BioHorizons is based in Birmingham, Alabama.
The NAICS codes for BioHorizons are [339, 33].
The SIC codes for BioHorizons are [384, 38].